Copyright
©The Author(s) 2025.
World J Diabetes. Jul 15, 2025; 16(7): 107344
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.107344
Published online Jul 15, 2025. doi: 10.4239/wjd.v16.i7.107344
Table 1 Clinical trials of mesenchymal stem cell-based stem cell therapies for diabetes
MSCs source | Clinical trials | |||||
Diabetes | Type 1 diabetes | Type 2 diabetes | Diabetic foot | Diabetic nephropathy | Others | |
Umbilical cord-derived MSCs | NCT04972890 | NCT01143168 | NCT01142050 | NCT02672280 | NCT03288571 | NCT02745808 |
Bone marrow-derived MSCs | NCT02387749 | NCT01157403 | NCT00644241 | NCT01686139 | ||
Adipose-derived MSCs | NCT01257776 | NCT02940418 | NCT06605508 | NCT03259217 | NCT04869761 | |
MSCs from other sources | NCT02384018 | NCT01496339 | NCT06003530 | |||
Unknown origin MSCs | NCT04776239 | NCT00646724 | NCT01786707 | NCT02304588 |
- Citation: Zuo DB, Wang CH, Sang M, Sun XD, Chen GP, Ji KK. Stem cell therapy for diabetes: Advances, prospects, and challenges. World J Diabetes 2025; 16(7): 107344
- URL: https://www.wjgnet.com/1948-9358/full/v16/i7/107344.htm
- DOI: https://dx.doi.org/10.4239/wjd.v16.i7.107344